We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
Cap. Flow
-$1.78B
Cap. Flow %
-1.61%
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46M
2
PLTR icon
Palantir
PLTR
+$40.3M
3
SW
Smurfit Westrock
SW
+$39.2M
4
DELL icon
Dell
DELL
+$29.2M
5
AVTR icon
Avantor
AVTR
+$27.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$97.8M
2
LLY icon
Eli Lilly
LLY
+$58.2M
3
NVDA icon
NVIDIA
NVDA
+$48.6M
4
XOM icon
ExxonMobil
XOM
+$31.3M
5
BAC icon
Bank of America
BAC
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Financials 12.91%
3 Healthcare 11.38%
4 Consumer Discretionary 10.81%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSVN icon
3101
Bank7 Corp
BSVN
$481M
$155K ﹤0.01%
4,137
-199
-5% -$7.5K
CVGI icon
3102
Commercial Vehicle Group
CVGI
$147M
$154K ﹤0.01%
47,278
-2,351
-5% -$9.58K
TNYA icon
3103
Tenaya Therapeutics
TNYA
$163M
$154K ﹤0.01%
79,599
+1,439
+2% +$4.06K
MGA icon
3104
Magna International
MGA
$18.8B
$153K ﹤0.01%
3,739
RILY icon
3105
BRC Group Holdings
RILY
$289M
$153K ﹤0.01%
29,167
-24,196
-45% -$268K
GRFS
3106
Grifois
GRFS
$5.4B
$152K ﹤0.01%
17,122
+1,208
+8% +$9.83K
FENC icon
3107
Fennec Pharmaceuticals
FENC
$402M
$152K ﹤0.01%
30,388
+1,278
+4% +$7.39K
OBIO icon
3108
Orchestra BioMed
OBIO
$254M
$152K ﹤0.01%
29,547
+3,108
+12% +$20.3K
SMID icon
3109
Smith-Midland
SMID
$152M
$152K ﹤0.01%
4,544
+16
+0.4% +$512
JILL icon
3110
J. Jill
JILL
$283M
$151K ﹤0.01%
6,129
-365
-6% -$11.9K
HCM icon
3111
HUTCHMED
HCM
$2.17B
$151K ﹤0.01%
7,709
+156
+2% +$2.82K
NAGE
3112
Niagen Bioscience
NAGE
$247M
$150K ﹤0.01%
41,156
-4,363
-10% -$13.7K
SKIN icon
3113
SkinHealth Systems
SKIN
$85.7M
$150K ﹤0.01%
104,081
-9,358
-8% -$15.3K
CVRX icon
3114
CVRx
CVRX
$63.4M
$149K ﹤0.01%
16,970
-290
-2% -$2.64K
RNAC icon
3115
Cartesian Therapeutics
RNAC
$268M
$149K ﹤0.01%
9,274
+787
+9% +$12.3K
PRTH icon
3116
Priority Technology Holdings
PRTH
$444M
$148K ﹤0.01%
21,742
-2,040
-9% -$11.4K
TSQ icon
3117
Townsquare Media
TSQ
$118M
$148K ﹤0.01%
14,589
+1,929
+15% +$20.7K
LNZA icon
3118
LanzaTech
LNZA
$69.8M
$148K ﹤0.01%
776
-61
-7% -$9.97K
AEM icon
3119
Agnico Eagle Mines
AEM
$90.5B
$147K ﹤0.01%
1,829
-80
-4% -$6.2K
EGAN icon
3120
eGain
EGAN
$201M
$147K ﹤0.01%
28,749
-748
-3% -$4.8K
TWIN icon
3121
Twin Disc
TWIN
$348M
$145K ﹤0.01%
11,614
-2,040
-15% -$26.2K
PESI icon
3122
Perma-Fix Environmental Services
PESI
$383M
$144K ﹤0.01%
11,767
-1,433
-11% -$15.3K
GRVY
3123
GRAVITY
GRVY
$473M
$144K ﹤0.01%
2,424
+85
+4% +$5.84K
PAYS icon
3124
Paysign
PAYS
$705M
$143K ﹤0.01%
38,945
+3,110
+9% +$14.2K
FNV icon
3125
Franco-Nevada
FNV
$46B
$143K ﹤0.01%
1,150

Similar funds

RhumbLine Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
  • RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
  • RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
  • RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
  • RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
  • RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.